3644 results for «2836»

Filter By

3644 results

Rapid-Fire clinical cases: Session 3

28 Nov 2022 – From PCR London Valves 2022

Consult this session to discover a selection of clinical cases presented during PCR LV 2022: tunnel stent technique as an alternative treatment for left main protection in valve-in-valve TAVI, coronary embolisation due to valve-in-valve aortic prothesis thrombosis, aortic prosthetic valve dysfunction due to endocarditis, and more!

Rapid-Fire clinical cases: Session 3

Challenging scenarios: bioprosthetic valve dysfunction

28 Nov 2022 – From PCR London Valves 2022

Consult this session to learn more about the different causes of bioprosthetic valve dysfunction and the best options (surgical, transcatheter or medical) for the management of patients with this kind of dysfunction, as well as to discover how valve design impacts on durability and what the future holds...

Challenging scenarios: bioprosthetic valve dysfunction

Rapid-fire abstracts: Session 6

28 Nov 2022 – From PCR London Valves 2022

Consult this session to discover a selection of abstracts presented during PCR LV 2022: hydrodynamic performance of ACURATE neo2 for valve-in-valve across different surgical bioprostheses, impact of leaflets splitting on coronary access after redo TAVI in failed supra-annular platforms, same-day discharge after TF and alternate access...

Rapid-fire abstracts: Session 6

Optimal management of right ventricular pacing leads in patients with tricuspid regurgitation

28 Nov 2022 – From PCR London Valves 2022

Consult these presentations to learn more about the consequences of right ventricular pacing lead implantation on tricuspid valve function, the diagnosis and imaging assessment of lead-induced tricuspid regurgitation and the possible treatment options for patients with right ventricular pacing leads and significant tricuspid regurgitation.

Optimal management of right ventricular pacing leads in patients with tricuspid regurgitation

Rapid-fire abstracts: Session 7

28 Nov 2022 – From PCR London Valves 2022

Consult this session to discover a selection of abstracts presented during PCR LV 2022: contemporary outcome of high surgical risk mitral regurgitation, quantitative flow ratio vs. FFR for coronary functional evaluation in patients undergoing TAVI, videodensitometric quantification of paravalvular leak after implantation of the new Myval-Octacor,...

Rapid-fire abstracts: Session 7

PCR London Valves 2022 Welcome Ceremony

27 Nov 2022 – From PCR London Valves 2022

Consult this session to watch PCR LV 2022 Welcome Ceremony, and learn more about the track leaders, the programme producers, as well as the latest updates regarding this congress.

PCR London Valves 2022 Welcome Ceremony

TAVI complications: Session 4

29 Nov 2022 – From PCR London Valves 2022

With this selection of challenging cases, discover how to face various TAVI complications, such as: annular perforation, lost wire, aortoiliac rupture, bilateral coronary ostial occlusion, and much more!

TAVI complications: Session 4

Rapid-fire abstracts: Session 10

29 Nov 2022 – From PCR London Valves 2022

Discover a selection of abstracts presented during PCR LV 2022: trends in utilisation of percutaneous tricuspid valve vegetation debulking in endocarditis 2017-19, association of TRI-SCORE with clinical outcomes after transcatheter tricuspid valve repair, transcatheter edge-to-edge repair vs. percutaneous annuloplasty for tricuspid regurgitation, and more!

Rapid-fire abstracts: Session 10

Rapid-fire clinical cases: Session 5

29 Nov 2022 – From PCR London Valves 2022

Discover a selection of cases submitted at PCR LV 2022 in this session: subacute thrombosis of a balloon-expandable aortic bioprosthesis, left axillary access for TAVI in a patient with two IMA grafts and a left side implanted pacemaker, avoiding paravalvular leak using computer simulation in bicuspid TAVI,...

Rapid-fire clinical cases: Session 5

Rapid-fire abstracts: Session 11

29 Nov 2022 – From PCR London Valves 2022

Discover a selection of abstracts presented during PCR LV 2022: the impact of cerebral embolic protection devices on acute ischaemic stroke complicating TAVI, TTVR clinical results prediction based on surgical risk scores, effects of tricuspid transcatheter edge-to-edge repair on tricuspid annular diameter, and much more!

Rapid-fire abstracts: Session 11

Rapid-fire clinical cases: Session 6

29 Nov 2022 – From PCR London Valves 2022

Discover a selection of abstracts presented during PCR LV 2022: valve-in-valve implant in a dysfunctional tricuspid bioprosthesis, first patient in TRICURE FIH trial, challenging percutaneous closure of prosthetic paravalvular leaks, and more!

Rapid-fire clinical cases: Session 6

Rapid-fire clinical cases: Session 7

29 Nov 2022 – From PCR London Valves 2022

Consult this session to discover a selection of abstracts presented during PCR LV 2022: simultaneous transcatheter edge-to-edge repair of mitral and tricuspid valve, transcatheter valve implantation in mitral and tricuspid valve position, TEER failure in mitral and tricuspid position: troubleshooting approach for a rare but still eventful case,...

Rapid-fire clinical cases: Session 7

Complex scenarios during mitral valve-in-valve, valve-in-ring or valve-in-MAC procedures - a case-based approach

29 Nov 2022 – From PCR London Valves 2022

Discover some complex scenarios during mitral valve-in-valve, valve-in-ring or valve-in-MAC procedures with these presentations, and learn more about the essential role of TOE and CT imaging in predicting procedural complexity, the pre-emptive techniques and strategies to avoid left ventricular outflow tract obstruction as well as the bailout emergency techniques when...

Complex scenarios during mitral valve-in-valve, valve-in-ring or valve-in-MAC procedures - a case-based approach

Mitral and tricuspid patients are different from the TAVI population - Impact on clinical care

28 Nov 2022 – From PCR London Valves 2022

Consult this session to learn more about the different needs of mitral and tricuspid patients, to appreciate what optimal medical therapy really means and to improve your knowledge of the anticoagulant requirements for different patient populations.

Mitral and tricuspid patients are different from the TAVI population - Impact on clinical care

Complex left main PCI - Session with LIVE case

15 Dec 2022 – From GulfPCR-GIM 2022

Follow the discussion around the case presented LIVE in this GulfPCR-GIM 2022 session of a 68-year-old male patient with DM, HTN and hyperlipidaemia, who presented with constant exertional chest pain with class 3 angina for several weeks, and find out more about complex LM PCI.

Complex left main PCI

Severe mitral and tricuspid regurgitation

15 Dec 2022 – From GulfPCR-GIM 2022

This GulfPCR-GIM 2022 session aims to illustrate the role of mitral TEER in patients with significant MR and cardiogenic shock, to demonstrate the importance of early detection, but also to show that earlier referral and treatment of patients with significant TR is essential to prevent patients...

Severe mitral and tricuspid regurgitation

Challenging CTO cases - Session 2

14 Dec 2022 – From GulfPCR-GIM 2022

This GulfPCR-GIM 2022 session compiles 5 challenging CTO cases and explains how to handle them. Study for example a flush ostial RCA-CTO, PWS in a CTO feeding vessel, rotablation and intravascular lithotripsy in three-vessel disease with IVUS, or rotaburr incarceration.

Challenging CTO cases - Session 2

Mitral complications

28 Nov 2022 – From PCR London Valves 2022

Because we can all be confronted with unexpected complications, this session of PCR LV 2022 proposes to study 5 specific cases such as an early redo mitral transcatheter edge-to-edge repair after single leaflet detachment or an unexpected cause of worsening dyspnoea after edge-to-edge mitral repair.

Mitral complications

EuroPCR 2021 Hotlines / Late-Breaking Trials in ACS: COOL AMI EU pivotal rial and more!

21 May 2021 – From EuroPCR 2021

Find out more about various studies & registries in ACS:

  • COOL AMI EU pivotal trial
  • Complete versus incomplete revascularization in NSTEMI patients
  • Non-hyperaemic IMRangio and long-term clinical outcome in STEMI
EuroPCR 2021 Hotlines / Late-Breaking Trials in ACS: COOL AMI EU pivotal rial and more!

EuroPCR 2021 Hotlines / Late-Breaking Trials: POEM, CEL-02, and PENDULUM

21 May 2021 – From EuroPCR 2021

Find out more about various studies & registries in drugs & devices:

  • POEM study: 1-month DAPT after PCI with bioresorbable-polymer EES in HBR patients
  • CEL-O2 trial: a novel rapid glycoprotein IIb/IIIa inhibitor(RUC-4) for STEMI patients
  • PENDULUM registry study: impact of Clinical Outcomes and Platelet Reactivity After Percutaneous Coronary
EuroPCR 2021 Hotlines / Late-Breaking Trials: POEM, CEL-02, and PENDULUM
Didn’t find what you were looking for?